Mkts

Milestone Pharmaceuticals Inc.

NASDAQ: MIST
$0.76+0.07 (+10.10%)
As of Nov 6, 9:30 AM ET

Key statistics

Day range
0.700.77
52-week range
0.633.06
Today
Open0.72
Previous close0.76
Volume555.9K
Valuation
Market cap90.88M
P/E ratio—
EPS (TTM)-0.69
Income & risk
Dividend / yield—
Beta1.08
Avg volume766.5K
Discussion

MIST News

Stories mentioning MIST from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue238.000.00
Cost of Goods Sold14.000.00
Gross Profit224.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development3,2515,5213,9403,6694,9783,9403,9632,815
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(23,663)(17,257)(11,829)(12,531)(20,523)(12,348)(9,616)(9,662)
Interest Income1,732833.00874.00516.00697.00904.001,0801,186
Interest Expense
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(26,066)(17,409)(11,922)(12,966)(20,761)(12,363)(9,439)(9,363)
Earnings Per Share (Basic)(0.20)(0.12)(0.12)(0.20)(0.31)(0.18)(0.14)(0.14)
Earnings Per Share (Diluted)(0.20)(0.12)(0.12)(0.20)(0.31)(0.18)(0.14)(0.14)
Weighted Average Shares Outstanding (Basic)
Weighted Average Shares Outstanding (Diluted)

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About MIST

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) is a stock listed on the Nasdaq Stock Market under the ticker symbol MIST. It last traded at $0.7600 (Nov 6, 2026, 9:30 AM ET), up 10.1% on the day. That gives Milestone Pharmaceuticals a market capitalisation of $90.9M.

Over the past 52 weeks MIST has traded between $0.6300 and $3.06.

Revenue for the quarter ended Mar 31, 2026 was $238.0K; a net loss of $26.1M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$238.0K-$26.1M-10952.1%
Dec 31, 2025—-$17.4M—
Sep 30, 2025—-$11.9M—
Jun 30, 2025—-$13.0M—

From Milestone Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…